IL112992A0 - Recombinant viruses, their preparation and their use in gene therapy - Google Patents
Recombinant viruses, their preparation and their use in gene therapyInfo
- Publication number
- IL112992A0 IL112992A0 IL11299295A IL11299295A IL112992A0 IL 112992 A0 IL112992 A0 IL 112992A0 IL 11299295 A IL11299295 A IL 11299295A IL 11299295 A IL11299295 A IL 11299295A IL 112992 A0 IL112992 A0 IL 112992A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- gene therapy
- recombinant viruses
- viruses
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9403191A FR2717496B1 (fr) | 1994-03-18 | 1994-03-18 | Virus recombinants, préparation et utilisation en thérapie génique. |
Publications (1)
Publication Number | Publication Date |
---|---|
IL112992A0 true IL112992A0 (en) | 1995-06-29 |
Family
ID=9461190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11299295A IL112992A0 (en) | 1994-03-18 | 1995-03-14 | Recombinant viruses, their preparation and their use in gene therapy |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0750676A1 (es) |
JP (1) | JPH09510358A (es) |
KR (1) | KR970701784A (es) |
AU (1) | AU703793B2 (es) |
CA (1) | CA2184200A1 (es) |
FI (1) | FI963674A0 (es) |
FR (1) | FR2717496B1 (es) |
IL (1) | IL112992A0 (es) |
MX (1) | MX9603490A (es) |
NO (1) | NO963559L (es) |
WO (1) | WO1995025804A1 (es) |
ZA (1) | ZA952244B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830857A (en) * | 1995-07-14 | 1998-11-03 | Amgen Inc. | Method of treating epilepsy |
FR2753379B1 (fr) | 1996-09-13 | 1998-10-30 | Rhone Poulenc Rorer Sa | Methode de traitement de la sclerose laterale amyotrophique |
AU2001259453B2 (en) * | 2000-05-05 | 2006-08-31 | Beth Israel Deaconess Medical Center | Methods for stimulating nervous system regeneration and repair by regulating arginase 1 and polyamine synthesis |
WO2019162942A1 (en) * | 2018-02-20 | 2019-08-29 | Carmel Haifa University Economic Corporation Ltd. | Compositions and methods for delivery and expression of small inhibitory peptides and use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU675409B2 (en) * | 1991-07-10 | 1997-02-06 | Regeneron Pharmaceuticals, Inc. | Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules |
AU3129793A (en) * | 1991-11-08 | 1993-06-07 | General Hospital Corporation, The | Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration |
FR2688514A1 (fr) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
WO1994003199A1 (en) * | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Method of enhancing differentiation and survival of neuronal precursor cells |
AU692423B2 (en) * | 1992-09-25 | 1998-06-11 | Institut National De La Sante Et De La Recherche Medicale | Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
FR2704234B1 (fr) * | 1993-04-22 | 1995-07-21 | Centre Nat Rech Scient | Virus recombinants, preparation et utilisation en therapie genique. |
-
1994
- 1994-03-18 FR FR9403191A patent/FR2717496B1/fr not_active Expired - Fee Related
-
1995
- 1995-03-02 KR KR1019960705207A patent/KR970701784A/ko not_active Application Discontinuation
- 1995-03-02 MX MX9603490A patent/MX9603490A/es not_active Application Discontinuation
- 1995-03-02 CA CA002184200A patent/CA2184200A1/fr not_active Abandoned
- 1995-03-02 JP JP7524417A patent/JPH09510358A/ja active Pending
- 1995-03-02 WO PCT/FR1995/000250 patent/WO1995025804A1/fr not_active Application Discontinuation
- 1995-03-02 AU AU18962/95A patent/AU703793B2/en not_active Ceased
- 1995-03-02 EP EP95911371A patent/EP0750676A1/fr not_active Ceased
- 1995-03-14 IL IL11299295A patent/IL112992A0/xx unknown
- 1995-03-17 ZA ZA952244A patent/ZA952244B/xx unknown
-
1996
- 1996-08-26 NO NO963559A patent/NO963559L/no not_active Application Discontinuation
- 1996-09-17 FI FI963674A patent/FI963674A0/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO963559L (no) | 1996-08-26 |
AU703793B2 (en) | 1999-04-01 |
JPH09510358A (ja) | 1997-10-21 |
ZA952244B (en) | 1996-01-16 |
KR970701784A (ko) | 1997-04-12 |
CA2184200A1 (fr) | 1995-09-28 |
FR2717496A1 (fr) | 1995-09-22 |
EP0750676A1 (fr) | 1997-01-02 |
FR2717496B1 (fr) | 1996-04-12 |
FI963674A (fi) | 1996-09-17 |
WO1995025804A1 (fr) | 1995-09-28 |
FI963674A0 (fi) | 1996-09-17 |
MX9603490A (es) | 1997-03-29 |
AU1896295A (en) | 1995-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111681A0 (en) | Recombinant viruses and their use in gene therapy | |
ZA951803B (en) | Recombinant viruses their preparation and their therapeutic use | |
ZA952563B (en) | Recombinant viruses their preparation and their use in gene therapy | |
IL115584A0 (en) | Viral vectors and their use in gene therapy | |
HUP9801216A3 (en) | Dna molecules, preparation thereof and use thereof in gene therapy | |
HUP9802217A3 (en) | Recombinant mva virus, and the use thereof | |
EP0710667A3 (de) | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung | |
AU4032893A (en) | Human papilloma virus genes and their use in gene therapy | |
HU9503751D0 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
ZA945012B (en) | Viral vectors and their use in gene therapy | |
SG54275A1 (en) | Dna coding for decarbamylase improved in thermostability and use thereof | |
ZA949103B (en) | Recombinant viruses and their use in gene therapy | |
AU4556597A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
IL112453A0 (en) | Human repair proteins, dna(rna) encoding them and their preparation | |
HUP9901035A3 (en) | Parapoxviruses containing foreign dna, their production and their use in vaccines | |
HUP9903886A3 (en) | Azacycloalcane derivatives, preparation thereof and their applications in therapy | |
ZA961998B (en) | Recombinant viruses expressing lecithin-cholesterol acyl-transferase and their use in gene therapy | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
ZA952242B (en) | Recombinant viruses their preparation and their use in gene therapy | |
AU9269898A (en) | Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy | |
ZA978772B (en) | N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy. | |
IL112992A0 (en) | Recombinant viruses, their preparation and their use in gene therapy | |
ZA959904B (en) | Iminooxymethyleneanilides thei preparation and their use | |
IL133536A0 (en) | 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy | |
IL112994A0 (en) | Recombinant viruses, their preparation and their use in gene therapy |